John Mason@johnkmasonWasn't remotely the bottom. Been a very painful 2 months, largest drawdown in $ terms ever (7-figures), though 1/3 was $QURE 4Y data. Still believe $ABVX will be acquired by Feb- into or exiting JPM. Will switch call spreads back to shares if not going into Crohn's. 🧵
John Mason@johnkmasonTook a shot at calling at least a ST bottom in $ABVX. Spent all remaining cash across IRAs at sub- $117 today- fully allocated now at a $121.81 avg across all post-Jul 1 buys. If it falls sub-$110, will likely switch to calls. If it gets back above $130, I'll trim.
